Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Top Cited Papers
- 1 May 2006
- journal article
- genitourinary cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (13), 1997-2005
- https://doi.org/10.1200/jco.2005.03.9594
Abstract
Purpose The purpose of this study was to evaluate the impact of immunologic prognostic factors in combination with established clinical prognostic factors in patients with metastatic renal cell car...Keywords
This publication has 43 references indexed in Scilit:
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’ImmunothérapieAnnals of Oncology, 2002
- Thirteen‐year, long‐term efficacy of interferon 2α and interleukin 2‐based home therapy in patients with advanced renal cell carcinomaCancer, 2002
- Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer PatientsUrologia Internationalis, 2000
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 1999
- Natural history and therapy of metastatic renal cell carcinomaCancer, 1997
- The Impact of Interleukin-2 on Survival in Renal Cancer: A Multivariate AnalysisCancer Biotherapy, 1993
- Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2Annals of Oncology, 1992
- Renal Cell Carcinoma: Natural History and Results of TreatmentJournal of Urology, 1978